These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1294938)

  • 1. Pharmacokinetic and pharmacodynamic significance of antidepressant drug metabolites.
    Caccia S; Garattini S
    Pharmacol Res; 1992 Dec; 26(4):317-29. PubMed ID: 1294938
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic aspects of antidepressant treatment in the elderly.
    Norman TR
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):329-44. PubMed ID: 8475316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current concepts on the subject of properties and use of antidepressants].
    Białecka M
    Pol Merkur Lekarski; 1997 Apr; 2(10):295-7. PubMed ID: 9377672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant pharmacodynamics, pharmacokinetics, and drug interactions.
    Ereshefsky L
    Geriatrics; 1998 Dec; 53 Suppl 4():S22-33. PubMed ID: 9861902
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic considerations of antidepressant use in the elderly.
    DeVane CL; Pollock BG
    J Clin Psychiatry; 1999; 60 Suppl 20():38-44. PubMed ID: 10513858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetic imperative in late-life depression.
    Pollock BG
    J Clin Psychopharmacol; 2005 Aug; 25(4 Suppl 1):S19-23. PubMed ID: 16027556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving results with antidepressant drug therapy.
    Sussman N; Cancro R
    Compr Ther; 1990 Feb; 16(2):12-23. PubMed ID: 2311358
    [No Abstract]   [Full Text] [Related]  

  • 8. [Paraclinical monitoring of antidepressant prescription].
    Sechter D; Vandel S; Bonin B
    Encephale; 1995 Dec; 21 Spec No 4():39-41. PubMed ID: 8808345
    [No Abstract]   [Full Text] [Related]  

  • 9. [Switching and combining strategies of antidepressant medications].
    Charpeaud T; Moliere F; Bubrovszky M; Haesebaert F; Allaïli N; Bation R; Nieto I; Richieri R; Saba G; Bellivier F; Bennabi D; Holtzmann J; Camus V; Courtet P; Courvoisier P; d'Amato T; Doumy O; Garnier M; Bougerol T; Lançon C; Haffen E; Leboyer M; Llorca PM; Vaiva G; El-Hage W; Aouizerate B
    Presse Med; 2016 Mar; 45(3):329-37. PubMed ID: 26995511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant drug interaction considerations.
    Ereshefsky L
    Manag Care; 2001 Aug; 10(8 Suppl):10-3; discussion 18-22. PubMed ID: 11729432
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychopharmacologic treatment of depression in the medically ill.
    Beliles K; Stoudemire A
    Psychosomatics; 1998; 39(3):S2-19. PubMed ID: 9664784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant drug therapy.
    DeGennaro M; Hymen R; Crannell AM; Mansky PA
    Am J Nurs; 1981 Jul; 81(7):1304-10. PubMed ID: 6113760
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of antidepressant-cyclosporine pharmacokinetic interactions.
    Markowitz JS; Gill HS; Hunt NM; Monroe RR; DeVane CL
    J Clin Psychopharmacol; 1998 Feb; 18(1):91-3. PubMed ID: 9472853
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antidepressant therapy in internal diseases].
    Kapfhammer HP
    Internist (Berl); 1994 Sep; 35(9):832-41. PubMed ID: 7960565
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketamine may exert antidepressant effects via mediating the kynurenine pathway.
    Yang C; Zhou Z; Shi J; Yang J
    Expert Opin Ther Targets; 2011 Dec; 15(12):1423-4. PubMed ID: 22126323
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiac effects of antidepressant agents].
    Holm H; Luutonen S; Porela P
    Duodecim; 2001; 117(13):1305-10. PubMed ID: 12184118
    [No Abstract]   [Full Text] [Related]  

  • 17. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing.
    Bishop JR
    Clin Transl Sci; 2021 Jul; 14(4):1206-1209. PubMed ID: 34058073
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin (5-HT) receptor, 5-HT transporter and G protein-effector expression: implications for depression.
    Lesch KP; Aulakh CS; Wolozin BL; Murphy DL
    Pharmacol Toxicol; 1992; 71 Suppl 1():49-60. PubMed ID: 1480560
    [No Abstract]   [Full Text] [Related]  

  • 20. An overview of variability in drug response and traditional approaches to dosage regimen design.
    Risch SC
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():237A-238A. PubMed ID: 1498825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.